FDA.reportPublic FDA data

NDC 60505-6231-0 - Cefazolin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
60505-6231
Requested NDC
60505-6231-0
Package NDCs from labels
60505-6231-0, 60505-6231-5
Manufacturer
Apotex Corp. | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site) | Qilu Antibiotics Pharmaceutical Co., Ltd.
Effective date
2025-07-15
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Cefazolin for Injection, USPApotex Corp. | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd.(High Tech Zone Site) | Qilu Antibiotics Pharmaceutical Co., Ltd.2025-07-15HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60505-6231-0Cefazolin1 in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, FOR SOLUTION113
60505-6231-5Cefazolin25 in 1 CARTONINJECTION, POWDER, FOR SOLUTION2513

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60505-6231CEFAZOLIN INJECTION, POWDER, FOR SOLUTION [APOTEX CORP.]12Current NDC, Legacy NDC, 2 package rows20240220_0422fe47-c372-494f-bac2-612f550b44a4.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60505-6231-0EA - Each60505-62316533cda7-17d5-4947-93c1-05dc314ff1f212022-04-06
60505-6231-5EA - Each60505-623127e6f759-6db5-4c5d-91b1-330aed3468b712022-04-06

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 32 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.26de1ce9-06a9-486f-b27d-2ac635f018d12026-05-14Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINCivica, Inc.9ea55207-6d86-401e-b9b9-73c9534a233f2026-05-14Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.1dc9de56-e259-4546-a1db-23119a8a088e2026-05-14Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINWG Critical Care, LLC4f3a9248-a354-4c77-bf5b-9eed38f002192026-02-27Warnings, Adverse reactionsExact identifier
rxcui: 1665060
rxcui: 2630753
unii: P380M0454Z
CefazolinCEFAZOLINHospira, Inc62441488-fc97-4535-a249-4485fb0750222026-01-21Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINWG Critical Care, LLC00dd6da7-50a8-44c9-b2dc-7948973df3922026-01-07Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINCivica, Inc.c24e604f-16ca-4945-8e9d-277cc67a8c682025-11-20Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINCivica, Inc.1367568c-7d27-479f-a4c5-58e99942f6862025-11-01Warnings, Adverse reactionsExact identifier
rxcui: 1665060
unii: P380M0454Z
CEFAZOLINCEFAZOLINHenry Schein, Inc.197d5702-2c20-480e-8246-4d0d21f871be2025-10-27WarningsExact identifier
rxcui: 1665050
unii: P380M0454Z
CEFAZOLINCEFAZOLINHenry Schein Inc.922fb1a1-ad4c-4a12-8d5d-00fe13af18e82025-10-27Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CEFAZOLINCEFAZOLINHenry Schein, Inc.5a8c4bb2-a75e-4d7d-91fb-9a95f04fc94b2025-10-27Warnings, Adverse reactionsExact identifier
application number: ANDA203661
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINProPharma Distribution3d5cc73c-8a41-b285-e063-6294a90a609f2025-08-27Warnings, Adverse reactionsExact identifier
application number: ANDA203661
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.570d2583-9ce7-4941-bf7c-6ebc783c0f2b2025-07-25Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINApotex Corp.0422fe47-c372-494f-bac2-612f550b44a42025-07-15Warnings, Adverse reactionsExact identifier
application number: ANDA203661
ndc (package): 60505-6231-5
ndc (package): 60505-6266-0
ndc (package): 60505-6142-5
ndc (package): 60505-6231-0
ndc (package): 60505-6142-0
ndc (package): 60505-6266-5
ndc (product): 60505-6266
ndc (product): 60505-6231
ndc (product): 60505-6142
ndc11 (package): 60505623100
rxcui: 1665060
rxcui: 2630753
rxcui: 1665050
spl id: 10b501ca-c77f-4b3f-85df-ddf2715bfcd0
spl set id: 0422fe47-c372-494f-bac2-612f550b44a4
unii: P380M0454Z
CefazolinCEFAZOLINWG Critical Care, LLCf17160d4-fc42-4f9c-abb8-d04f01ae6dd12025-04-07Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
Cefazolin SodiumCEFAZOLIN SODIUMB. Braun Medical Inc.17f8f038-c204-4dab-80d7-6f7ac41ddbec2025-03-10Warnings, Adverse reactionsExact identifier
rxcui: 1665060
rxcui: 2630753
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINSandoz Inc18e7366a-1b3e-4010-8f4a-dd559d4f21462025-02-05Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CEFAZOLINCEFAZOLIN SODIUMSamson Medical Technologies, L.L.C.cf13db9c-d8a1-489f-9aa0-fc70839d4bbc2025-01-08Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.6c7761d3-c154-4802-9876-627cd42913f02024-12-31Warnings, Adverse reactionsExact identifier
rxcui: 1665060
rxcui: 2630753
unii: P380M0454Z
Cefazolin SodiumCEFAZOLIN SODIUMDirect_rx22dfc2e4-07a7-8d13-e063-6394a90a3e9f2024-09-24Warnings, Adverse reactionsExact identifier
application number: ANDA203661
rxcui: 1665050
unii: P380M0454Z

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.